For instance, IRS-2 mRNA expression in liver biopsy samples from NAFLD [9, 12] and NASH [13] subjects were reported to be lower than in those from subjects with normal livers, while there is a report indicating that IRS-2 mRNA expression increased progressively with the severity of NASH [14]. This evidence concerns the gene IRS2 and metabolic dysfunction-associated steatotic liver disease.